HERMAN CLEMENTS: Open Payments
NPI 1427019371 · SEARCY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$51,839 in 104 payments from 8 companies in 2025. Trend: 2023 $23,873 · 2024 $31,953 · 2025 $51,839
Speaker / faculty: $33,200Honoraria: $12,800Travel & lodging: $4,284Food & beverage: $1,555
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 69 | $34,493 |
| Tris Pharma Inc | 26 | $17,162 |
| Lundbeck LLC | 3 | $51 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $41 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
Products named: VRAYLAR, Dyanavel XR, REXULTI, CAPLYTA, UZEDY, Qelbree, Auvelity, INVEGA SUSTENNA.
Industry payments across AR — which companies pay providers there.
